Cullen/Frost Bankers, Inc. Charles River Laboratories International, Inc. Transaction History

Cullen/Frost Bankers, Inc.

$7.23 Billion
Q3 2024

A detailed history of Cullen/Frost Bankers, Inc. transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Cullen/Frost Bankers, Inc. holds 21,673 shares of CRL stock, worth $3.54 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

21,673

Previous 25,048 13.47%

Holding current value

$3.54 Million

Previous $5.17 Million 17.49%

% of portfolio

0.06%

Previous 0.08%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 06, 2024	SELL	$187.96 - $245.29 $634,365 - $827,853	-3,375 Reduced 13.47%	21,673 $4.27 Million
Q2 2024 Aug 05, 2024	SELL	$206.39 - $268.73 $26,005 - $33,859	-126 Reduced 0.5%	25,048 $5.17 Million
Q1 2024 May 10, 2024	BUY	$203.52 - $273.43 $2,238 - $3,007	11 Added 0.04%	25,174 $6.82 Million
Q4 2023 Feb 06, 2024	SELL	$164.52 - $238.84 $111,544 - $161,933	-678 Reduced 2.62%	25,163 $5.95 Million
Q3 2023 Nov 02, 2023	BUY	$194.44 - $217.61 $146,996 - $164,513	756 Added 3.01%	25,841 $5.06 Million
Q2 2023 Aug 04, 2023	BUY	$183.71 - $210.25 $180,403 - $206,465	982 Added 4.07%	25,085 $5.27 Million
Q1 2023 May 05, 2023	BUY	$191.89 - $259.92 $3.97 Million - $5.37 Million	20,671 Added 602.3%	24,103 $4.86 Million
Q4 2022 Feb 13, 2023	SELL	$197.11 - $250.07 $176,216 - $223,562	-894 Reduced 20.67%	3,432 $747,000
Q3 2022 Nov 07, 2022	SELL	$182.44 - $250.54 $52,360 - $71,904	-287 Reduced 6.22%	4,326 $851,000
Q2 2022 Aug 05, 2022	BUY	$204.13 - $302.4 $89,000 - $131,846	436 Added 10.44%	4,613 $987,000
Q1 2022 May 09, 2022	BUY	$255.51 - $362.11 $131,587 - $186,486	515 Added 14.06%	4,177 $1.19 Million
Q4 2021 Feb 07, 2022	SELL	$351.38 - $448.68 $439,927 - $561,747	-1,252 Reduced 25.48%	3,662 $1.38 Million
Q3 2021 Nov 04, 2021	SELL	$372.64 - $458.3 $9,688 - $11,915	-26 Reduced 0.53%	4,914 $2.03 Million
Q2 2021 Aug 05, 2021	BUY	$294.17 - $371.65 $93,546 - $118,184	318 Added 6.88%	4,940 $1.83 Million
Q1 2021 May 05, 2021	SELL	$249.67 - $299.48 $13,232 - $15,872	-53 Reduced 1.13%	4,622 $1.34 Million
Q4 2020 Feb 08, 2021	SELL	$222.0 - $252.62 $78,810 - $89,680	-355 Reduced 7.06%	4,675 $1.17 Million
Q3 2020 Nov 05, 2020	SELL	$175.56 - $226.45 $14,571 - $18,795	-83 Reduced 1.62%	5,030 $1.14 Million
Q2 2020 Aug 05, 2020	BUY	$118.84 - $189.72 $568,887 - $908,189	4,787 Added 1468.4%	5,113 $891,000
Q1 2020 May 01, 2020	BUY	$98.9 - $178.34 $10,186 - $18,369	103 Added 46.19%	326 $41,000
Q4 2019 Feb 06, 2020	BUY	$126.05 - $152.76 $28,109 - $34,065	223 New	223 $34,000

Others Institutions Holding CRL

# of Institutions

692

Shares Held

51.7M

Call Options Held

259K

Put Options Held

463K

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.3B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen/Frost Bankers, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cullen/Frost Bankers, Inc. with notifications on news.

Account

Cullen/Frost Bankers, Inc. Charles River Laboratories International, Inc. Transaction History